No takes yet. Share an insight, caveat, or question.
Experimental study demonstrates improved solvent tolerance and chemical titers in recombinant Escherichia coli expressing phasin PhaP, highlighting a novel strategy for bioproduction.
Mezzina et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: